Cargando…

SMARCB1/INI1-deficient pancreatic undifferentiated rhabdoid carcinoma mimicking solid pseudopapillary neoplasm: A case report and review of the literature

BACKGROUND: SMARCB1/INI1-deficient pancreatic undifferentiated rhabdoid carcinoma is a very aggressive tumor that is rarely reported in the literature. The tumor has a predominant rhabdoid cell component and different patterns of growth have been reported. CASE SUMMARY: A 59-year-old woman presented...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hua, Yinan, Soni, Piyush, Larsen, Douglas, Zreik, Riyam, Leng, Bing, Rampisela, Debby
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520612/ https://www.ncbi.nlm.nih.gov/pubmed/33024402 http://dx.doi.org/10.3748/wjg.v26.i36.5520

Ejemplares similares

Malignant rhabdoid tumor of the kidney in an adult with loss of INI1 expression and mutation in the SMARCB1 gene
por: Han, Eunkyung, et al.
Publicado: (2021)

Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic Neoplasms
por: Haberecker, Martina, et al.
Publicado: (2022)

SMARCB1/INI1-deficient tumors of adulthood
por: Parker, Nathaniel A., et al.
Publicado: (2020)

SMARCB1(INI1)-deficient Sinonasal Basaloid Carcinoma: A Novel Member of the Expanding Family of SMARCB1-deficient Neoplasms
por: Agaimy, Abbas, et al.
Publicado: (2014)

Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumor
por: Duan, Zejun, et al.
Publicado: (2022)

SMARCB1/INI1-Deficient Extrarenal Rhabdoid Tumor: A Case Report of a Rare and Aggressive Soft Tissue Sarcoma
por: Parker, Nathaniel A, et al.
Publicado: (2020)

Oncogenic roles of SMARCB1/INI1 and its deficient tumors
por: Kohashi, Kenichi, et al.
Publicado: (2017)

SMARCB1(INI-1)-Deficient Sinonasal Carcinoma: An Evolving Entity
por: Chung, Sei Y., et al.
Publicado: (2023)

Case report: administration of immune checkpoint inhibitor for SMARCB1 (INI1)-negative rhabdoid carcinoma with microsatellite instability (MSI)-high in the right colon
por: Kobayashi, Toshinori, et al.
Publicado: (2023)

SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis
por: Rousseau, Guillaume, et al.
Publicado: (2011)

INI1-Intact Sinonasal Carcinoma with Rhabdoid Features
por: Mulry, Erin, et al.
Publicado: (2021)

SMARCB1 (INI1) retained but SMARCA4 (BRG1) negative atypical teratoid/rhabdoid tumor arising at the bilateral cerebellopontine angles: a case report
por: Mitsui, Nobuyuki, et al.
Publicado: (2021)

Gastric undifferentiated carcinoma, INI1-negative
por: Gaggero, Gabriele, et al.
Publicado: (2022)

SMARCB1- and vimentin-positive esophageal carcinoma with undifferentiated components, rhabdoid features, and a good prognosis: a case report
por: Nagano, Hideki, et al.
Publicado: (2019)

Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors
por: Pathak, Rajiv, et al.
Publicado: (2021)

The significance of SMARCB1 in the pathogenesis of renal cell carcinoma with rhabdoid features
por: Wang, Yi-Wen, et al.
Publicado: (2021)

SMARCB1/INI1 loss in skull base conventional chordomas: a clinicopathological and molecular analysis
por: Righi, Alberto, et al.
Publicado: (2023)

INI1-negative colorectal undifferentiated carcinoma with rhabdoid features and postoperative rapidly growing liver metastases: a case report and review of the literature
por: Kojima, Masatsugu, et al.
Publicado: (2021)

Underreporting of SMARCB1 alteration by clinical sequencing: Integrative patho-genomic analysis captured SMARCB1/INI-1 deficiency in a vulvar yolk sac tumor
por: Wei, Christina H., et al.
Publicado: (2023)

The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report
por: Yoshida, Kazushi, et al.
Publicado: (2018)

SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma: A Systematic Review and Pooled Analysis of Treatment Outcomes
por: Lee, Victor Ho-Fun, et al.
Publicado: (2022)

INI1/SMARCB1 Rpt1 domain mimics TAR RNA in binding to integrase to facilitate HIV-1 replication
por: Dixit, Updesh, et al.
Publicado: (2021)

A case of retroperitoneal tumor displaying epithelial differentiation, prominent myxoid stroma and loss of INI1/SMARCB1
por: Rekhi, Bharat, et al.
Publicado: (2021)

The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation
por: Han, Zhi-Yan, et al.
Publicado: (2016)

Targeting Polo-like kinase 1 in SMARCB1 deleted atypical teratoid rhabdoid tumor
por: Alimova, Irina, et al.
Publicado: (2017)

An Adrenal SMARCB1/INI1 Deficient Proximal Epithelioid Sarcoma in a Middle-Aged Female: A Case Report
por: Brodie, Zachary, et al.
Publicado: (2022)

Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells
por: Darr, Jonatan, et al.
Publicado: (2015)

Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development
por: Vitte, Jeremie, et al.
Publicado: (2017)

ATRT-21. Contribution of germline mosaic alterations of SMARCB1 in rhabdoid tumor predisposition syndrome
por: Masliah-Planchon, Julien, et al.
Publicado: (2022)

SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors
por: Liu, Ning Qing, et al.
Publicado: (2023)

Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases
por: Holdhof, Dörthe, et al.
Publicado: (2020)

Case Report: Unclassified Renal Cell Carcinoma With Medullary Phenotype and SMARCB1/INI1 Deficiency, Broadening the Spectrum of Medullary Carcinoma
por: Valeri, Marina, et al.
Publicado: (2022)

A Novel Successful Case of Nasal and Sinus Yolk Sac Tumor With SMARCB1 (INI-1) Deficiency: A Case Report
por: He, Tianyu, et al.
Publicado: (2022)

Erratum to: ‘Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells’
por: Darr, Jonatan, et al.
Publicado: (2016)

Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers
por: Richer, Wilfrid, et al.
Publicado: (2017)

Primary intracerebral INI1-deficient rhabdoid tumor with CD34 immunopositivity in a young adult
por: Bodi, Istvan, et al.
Publicado: (2018)

SDPS-18 RHABDOID TUMOR PREDISPOSITION SYNDROME IN TWO INFANT SIBLINGS WITH ATYPICAL TERATOID RHABDOID TUMORS DUE TO A GERMLINE SMARCB1 MUTATION
por: Quintero, Ana, et al.
Publicado: (2023)

Extended pancreato-duodenectomy coupled with adjuvant chemotherapy for SMARCB1/INI1 deficient pancreatic carcinoma: A case report and literature review
por: Mugaanyi, Joseph, et al.
Publicado: (2021)

Global Chromatin Changes Resulting from Single-Gene Inactivation—The Role of SMARCB1 in Malignant Rhabdoid Tumor
por: Kenny, Colin, et al.
Publicado: (2021)

ATRT-11. PREVALENCE OF GERMLINE VARIANTS IN SMARCB1 INCLUDING SOMATIC MOSAICISM IN AT/RT AND OTHER RHABDOID TUMORS
por: Shirai, Ryota, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h3j9b3k8um17gltjkdi7of6pqo